A digital health company that uses artificial intelligence to predict health outcomes, improve accuracy of diagnosis, and personalise treatment options for people with diabetes has been successful in the latest round of the Artificial Intelligence in Health and Care Award.
MyWay Digital Health was one of 15 organisations to receive the funding (subject to contract), which was announced by Department of Health and Social Care (DHSC) on 16 June 2021. The AI Award is making £140 million available over four years to accelerate the testing and evaluation of artificial intelligence technologies which meet the aims set out in the NHS Long Term Plan.
The AI Award is one of the programmes that make up the NHS AI Lab, led by NHSX and delivered in partnership with the Accelerated Access Collaborative (AAC) and National Institute for Health Research (NIHR).
Dan Bamford, Deputy Director AI Award, Accelerated Access Collaborative, said:
‘Congratulations to MyWay Digital Health on their success as one of our winners in Round 2 of the AI Award. We look forward to working with them as they develop and test their technology further, so that more patients can benefit from this cutting-edge artificial intelligence.’
Dr Indra Joshi, Director of AI, NHSX, said:
‘With this latest round of AI Award winners, we now have an incredible breadth of expertise across a wide range of clinical and operational areas. Through this award, MyWay Digital Health will be at the forefront of applying artificial intelligence in new ways to transform health and care.’
For more information visit: https://www.gov.uk/government/news/36-million-boost-for-ai-technologies-to-revolutionise-nhs-care
